Randomised phase II study comparing topotecan/carboplatin administration for 5 versus 3 days in the treatment of extensive-stage small-cell lung cancer
Titel:
Randomised phase II study comparing topotecan/carboplatin administration for 5 versus 3 days in the treatment of extensive-stage small-cell lung cancer
Auteur:
Seifart, U. Fink, T. Schade-Brittinger, C. Hans, K. Mueller, C. Koschel, G. Schroeder, H. Lorenz, R. Dethling, J. Wolf, M.